Equistasi® Equistasi®

Category: News

HomeNews

Equistasi® joins the fight against the Covid-19

Equistasi® joins the fight against the Covid-19 emergency, in support of Mycroclean Italia industrial production of PPE protective clothing, accessories and devices. In this difficult moment, we’re working alongside the Mycroclean staff to supply intensive care units of hospitals in the Italian regions most affected by the epidemic. Today,…

Equistasi® clinical study accepted at the congress ISB/ASB 2019

The study “Effects of the Equistasi® neurological rehabilitation device on Parkinson’s disease patients” conducted by a team of professors and researchers at the University of Padua was accepted at the Congress of the International Society of Biomechanics (ISB/ASB 2019). It will convene in Calgary, Canada from July 31st to August…

Equistasi® A New Device for Neurorehabilitation | Dubai 18th November

Equistasi® will be the topic of discussion at the Conference ‘Equistasi® A New Device for Neurorehabilitation’ held at the Millennium Plaza Dubai, on November 18, 2018 at 06:00 pm. The company has put together an interesting programme for attendees. The medical staff as well…

New Open-Label Pilot Study: Equistasi In Childhood Ataxia

The medical division of Bambino Gesù Ospedale Pediatrico (IRCCS), Rome, has conducted an open-label pilot study to evaluate the feasibility, safety and effectiveness of non-invasive focal mechanical vibrations (NIFMV) generated by Equistasi®. This study involved a cohort of 10 patients with childhood ataxia, a phenomenological category including different conditions still…

Contact Us

Equistasi Srl è parte del Gruppo Mycroclean Italia, leader nel settore della produzione e decontaminazione particellare di indumenti per camere sterili. L'azienda distribuisce le mascherine protettive BP2020V3 e BP2020V3TN.

Per informazioni su prenotazioni e ordini, contattare il numero 0250047009.